Mooren’s ulcer

References

• Bowman W. The parts concerned in the operations of the eye. 1849; Case 12: 112, cited by Nettleship E, Chronic serpiginous ulcer of the cornea (Mooren’s ulcer). Trans. Ophthalmol. Soc. UK22, 103–104 (1902).
   Google Scholar
• Mooren A. Ulcus rodens, ophalmiatriche beobachtungen. Berlin: Hirschwald A, 107–110 (1867).
   Google Scholar
• Taylor CJ, Smith SI, Morgan CH et al. HLA and Mooren’s ulceration. Br. J. Ophthalmol.84, 72–75 (2000).
   PubMedGoogle Scholar
• Kietzman B. Moorens ulcer in Nigeria. Am. J. Ophthalmol.65, 679–685 (1968).
   PubMed Web of Science ®Google Scholar
• Wood TO, Kaufman HE. Mooren’s ulcer. Am. J. Ophthalmol.71, 417–422 (1971).
   PubMed Web of Science ®Google Scholar
• Kabuni M, Maertens K. L’ulcus rodens ou l’ulcer de Mooren en Republique du Zaire. Bull. Soc. Belg. Ophthalmol.170, 612–620 (1975).
   PubMedGoogle Scholar
• Trojan HJ. Ulcus rodens (Mooren) C Aspekte der atiologie, des verlaufs und der therapie. Klin. Monatsbl. Augenheilkd.174, 166–176 (1979).
   PubMedGoogle Scholar
• Majekodunmi AA. Ecology of Mooren’s ulcer in Nigeria. Doc. Ophthalmol.49, 211–219 (1980).
   PubMedGoogle Scholar
• Stilma JS. Conjunctival excision or lamellar scleral autograft in 38 Mooren’s ulcers from Sierra Leone. Br. J. Ophthalmol.67, 475–478 (1983).
   PubMedGoogle Scholar
• Zegans ME, Srinivasan M, McHugh T et al. Mooren ulcer in South India: serology and clinical risk factors. Am. J. Ophthalmol.128, 205–210 (1999).
   PubMed Web of Science ®Google Scholar
• Gnandoss AS. An analysis of ten cases of Mooren ulcer. Ind. J. Ophthalmol.22, 22–24 (1974).
   PubMedGoogle Scholar
• Zelefsky JR, Srinivasan M, Kundu A et al. Hookworm infestation as a risk factor for Mooren’s ulcer in South India. Ophthalmology114(3), 450–453 (2007).
   PubMedGoogle Scholar
• Srinivasan M, Zegans ME, Zelefsky JR et al. Clinical characteristics of Mooren’s ulcer in South India. Br. J. Ophthalmol.91, 570–575 (2007).
   PubMed Web of Science ®Google Scholar
• Chen J, Xie H, Wang Z et al. Mooren’s ulcer in China: a study of clinical characteristics and treatment. Br. J. Ophthalmol.84, 1244–1249 (2000).
   PubMed Web of Science ®Google Scholar
• Sheu SJ, Shyu JS, Chen LM et al. Ocular manifestations of tuberculosis. Ophthalmology108, 1580–1585 (2001).
   PubMed Web of Science ®Google Scholar
• Terson A. Keratite syphilitique ulceree. Presee. Med.36, 1179–1180 (1928).
   Google Scholar
• Messmer EM, Foster CS. Vasculitic peripheral ulcerative keratitis. Surv. Ophthalmol.43(5), 379 (1999).
   PubMed Web of Science ®Google Scholar
• Ladas JG, Mondino BJ. Systemic disorders associated with peripheral corneal ulceration. Curr. Opin. Ophthalmol.11(6), 468–471 (2000).
   PubMedGoogle Scholar
• Read RW. Clinical mini-review: systemic lupus erythematosus and the eye. Ocul. Immunol. Inflamm.12(2), 87–99 (2004).
   PubMed Web of Science ®Google Scholar
• Austin P, Green WR, Sallyer DC et al. Peripheral corneal degeneration and occlusive vasculitis in Wegener’s granulomatosis. Am. J. Ophthalmol.85(3), 311–317 (1978).
   PubMedGoogle Scholar
• Acharya N, Srinivasan M, Kundu A et al. Mooren’s ulcer following cataract extraction. Eur. J. Ophthalmol.18(3), 351–355 (2008).
   PubMedGoogle Scholar
• Kuriakose ET. Mooren’s ulcer: etiology and treatment. Am. J. Ophthalmol.65, 1064–1069 (1968).
   Google Scholar
• Trojan HJ. Aetiology and therapy of Mooren’s ulcer. Klin. Monatsbl. Augenheilkd.174, 166–176 (1979).
   PubMedGoogle Scholar
• van der Gaag R, Abdillahi H, Stilma JS, Vetter JC. Circulating antibodies against corneal epithelium and hookworm in patients with Mooren’s ulcer from Sierra Leone. Br. J. Ophthalmol.67, 623–628 (1983).
   PubMedGoogle Scholar
• Levinson RD. Immunogenetics of ocular inflammatory disease. Tissue Antigens69, 105–112 (2007).
   PubMed Web of Science ®Google Scholar
• Zamecki KJ, Jabs DA. HLA typings in uveitis: use and misuse. Am. J. Ophthalmol.149, 189–193 (2010).
   PubMed Web of Science ®Google Scholar
• Zelefsky JR, Taylor CJ, Srinivasan M et al. HLA-DR17 and Mooren’s ulcer in South India. Br. J. Ophthalmol.92(2), 179–181 (2008).
   PubMedGoogle Scholar
• Gottsch JD, Eisinger SW, Liu SH, Scott AL. Calgranulin C has filaricidal and filiriastatic activity. Infect. Immun.67(12), 6631–6636 (1999).
   PubMedGoogle Scholar
• Gottsch JD, Li Q, Ashraf F et al. Cytokine-induced calgranulin C expression in keratocytes. Clin. Immunol.91, 34–40 (1999).
   PubMedGoogle Scholar
• Zhao JC, Jin XY. Immunological analysis and treatment of Mooren’s ulcer with cyclosporin A applied topically. Cornea12(6), 481–488 (1993).
   PubMedGoogle Scholar
• Stammen J, Althaus C, Sundmacher R. Mooren ulcer: 4 severe bilateral disease courses with systemic cyclosporine A therapy. Klin. Monbl. Augenheilkd.211(5), 306–311 (1997).
   PubMedGoogle Scholar
• Thomson AW. FK506 – how much potential? Immunol. Today10(1), 6–9 (1989).
   PubMedGoogle Scholar
• Miyazaki D, Tominaga T, Kakimaru-Hasegawa A et al. Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases. Ophthalmology115(6), 988–992 (2008).
   PubMed Web of Science ®Google Scholar
• Tiev KP, Borderie VM, Briant M et al. Severe Moorens ulcer: efficacy of monthly cyclophosphamide intravenous pulse treatment. Rev. Med. Interne.24(2), 118–122 (2003).
   PubMedGoogle Scholar
• Mouser JF, Hyams JS. Infliximab: a novel chimeric monoclonal antibody for the treatment of Crohn’s disease. Clin. Ther.21(6), 932–942 (1999).
   PubMed Web of Science ®Google Scholar
• Fontana L, Parente G, Neri P et al. Favourable response to infliximab in a case of bilateral refractory Mooren’s ulcer. Clin. Exp. Ophthalmol.35(9), 871–873 (2007).
   PubMedGoogle Scholar
• Saw VP, Cornelius N, Salama AD et al. Infliximab therapy for aggressive Mooren ulceration. Arch. Ophthalmol.126(5), 734 (2008).
   PubMedGoogle Scholar
• Cordero-Coma M, Benito MF, Fuertes CL et al. Adalimumab for Mooren’s ulcer. Ophthalmology116(8), 1589 (2009).
   PubMedGoogle Scholar
• Erdem U, Kerimoglu H, Gundogan FC, Dagli S. Treatment of Mooren’s ulcer with topical administration of interferon α2a. Ophthalmology114(3), 446–449 (2007).
   PubMedGoogle Scholar
• Moazami G, Auran JD, Florakis GJ et al. Interferon treatment of Mooren’s ulcers associated with hepatitis C. Am. J. Ophthalmol.119(3), 365–366 (1995).
   PubMed Web of Science ®Google Scholar
• Mavrakanas NA, Kiel R, Dosso AA. Autologous serum application in the treatment of Mooren’s ulcer. Klin. Monbl. Augenheilkd.224(4), 300–302 (2007).
   PubMedGoogle Scholar
• Hatou S, Dogru M, Ibrahim QM et al. The application of in vivo confocal scanning laser microscopy in the diagnosis and evaluation of treatment responses in Mooren’s ulcer. Invest. Ophthalmol. Vis. Sci. DOI: 10.1167/iovs.10-5906 (2011) (Epub ahead of print).
   Google Scholar
• Brown SI. Mooren’s ulcer treatment by conjunctival excision. Br. J. Ophthalmol.59, 675–682 (1975).
   PubMedGoogle Scholar
• Eiferman RA, Hyndiuk RA. IgE in limbal conjunctiva in Mooren’s ulcer. Can. J. Ophthalmol.12(3), 234–236 (1977).
   PubMedGoogle Scholar
• Sandinha T, Zaher SS, Roberts F et al. Superior forniceal conjunctival advancement pedicles (SFCAP) in the management of acute and impending corneal perforations. Eye20(1), 84–89 (2006).
   PubMedGoogle Scholar
• Solomon A, Meller D, Prabhasawat P et al. Amniotic membrane grafts for nontraumatic corneal perforations, descemetoceles and deep ulcers. Ophthalmology109(4), 694–703 (2002).
   PubMed Web of Science ®Google Scholar
• Ngan ND, Chau HT. Amniotic membrane transplantation for Mooren’s ulcer. Clin. Exp. Ophthalmol.39(5), 386–392 (2011).
   PubMedGoogle Scholar
• Basu S, Taneja M, Sangwan VS. Boston type 1 keratoprosthesis for severe blinding vernal keratoconjunctivitis and Mooren’s ulcer. Int. Ophthalmol.31(3), 219–222 (2011).
   PubMedGoogle Scholar